Roivant Sciences Ltd. (ROIV) Tops Q3 EPS by 48c

Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q3 EPS of $0.23, $0.48 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $9.02 million versus the consensus estimate of $8.14 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.

You May Also Be Interested In

• Meta is switching to Slack because it says it's better for AI agents - Business Insider
• Apple new CEO Ternus teases "phenomenal" iPhone launch in first memo
• Action Behavior Centers' Family Advocacy Team Meets with Congressional Leaders in Washington, D.C., to Discuss Access to ABA Therapy for Autism